Peritoneal Metastatic Gastric Cancer: Local Treatment Options and Recommendations.
Peritoneal metastasis is a common finding in patients with advanced gastric cancer. Beyond systemic chemotherapy, additive local treatments such as cytoreductive surgery and intraperitoneal chemotherapy are considered an inherent part of different multimodal treatment concepts for selected patients...
| Published in: | Current Oncology Vol. 31; no. 3; pp. 1445 - 1460 |
|---|---|
| Main Authors: | , , |
| Format: | Journal Article |
| Published: |
MDPI
Mar2024
|
| Online Access: | View this record in EBSCOhost |
| Summary: | Peritoneal metastasis is a common finding in patients with advanced gastric cancer. Beyond systemic chemotherapy, additive local treatments such as cytoreductive surgery and intraperitoneal chemotherapy are considered an inherent part of different multimodal treatment concepts for selected patients with peritoneal metastatic gastric cancer. This review article discusses the role of cytoreductive surgery (CRS) and intraperitoneal chemotherapy, including HIPEC, NIPS, and PIPAC, as additive therapeutic options with curative and palliative intent. |
|---|